Inverness Medical Innovations Announces First Quarter 20...(ry write-ups recorded in connection with...),Health

(f) A $1.7 million net realized foreign currency loss associated with a cash escrow established in connection with the acquisition of BBI Holdings Plc.

(g) Write-off in the amount of $4.7 million for acquisition-related costs recorded in connection with the adoption of SFAS No. 141-R, Business Combinations, on January 1, 2009.

(h) Tax effect on adjustments as discussed above in notes (b), (c), (d), (e), (f) and (g).

(i) Included in the weighted average diluted common shares for the calculation of net income per common share on a GAAP basis for the three months ended March 31, 2009, are dilutive shares consisting of 1,023,000 common stock equivalent shares from the potential exercise of stock options and warrants. Potential dilutive shares consisting of 3,411,000 common stock equivalent shares from the potential conversion of convertible debt securities and potential dilutive shares consisting of 10,765,000 common stock equivalent shares from the potential conversion of Series B convertible preferred stock were not included in the calculation of net income per common share on a GAAP basis for the three months ended March 31, 2009 because inclusion thereof would be antidilutive.

(j) For the three months ended March 31, 2008, potential diluted shares were not used in the calculation of diluted net loss per common share under GAAP because inclusion thereof would be antidilutive.

(k) Included in the weighted average diluted common shares for the calculation of net income per common share for the three months ended March 31, 2009, on an adjusted cash basis, are dilutive shares consisting of 1,023,000 common stock equivalent shares from the potential exercise of stock options and warrants. Also included were potential dilutive shares consist
'/>"/>